PENNVAX-B

BIOLOGICAL3 trials

Sponsors

University of Pennsylvania, National Institute of Allergy and Infectious Diseases (NIAID), Inovio Pharmaceuticals

Conditions

HIV InfectionHIV InfectionsHIV-1 Infection

Phase 1

PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection

CompletedNCT00775424

University of PennsylvaniaHIV Infection

Start: 2008-09-30End: 2010-06-30Updated: 2016-08-25

Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults

CompletedNCT00991354

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2009-11-30End: 2011-03-31Updated: 2021-10-14

Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants

CompletedNCT01082692

Inovio PharmaceuticalsHIV-1 Infection, HIV Infections

Start: 2011-01-31End: 2012-08-31Updated: 2012-11-09